Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson's disease in Sweden: an exploratory study.
about
Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden.The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal.Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.Estimating the direct and indirect costs associated with Parkinson's disease.Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.Intestinal levodopa infusion: the Belgian experience.Trans-obturator tape compared with tension-free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis.The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
P2860
Q37806190-A8BD81E2-4F4F-43E6-B212-ADD83F9042A9Q37891050-283BD62A-AE5C-4A05-AADA-FDDCF6DF3ED2Q37924626-FD54FCBF-8835-495E-9F50-5B704669EB9AQ37955238-64713BEB-B9C7-423D-889B-B543E973FF8FQ38122127-2E0FF5CF-5BBD-43BB-848C-3E947D31CCBEQ38618871-29C37380-CD5B-4034-AA2C-2F42E4710FD9Q38989994-612800DB-A02A-42B1-B56E-50C0636B5C5DQ43485762-B8BE80D8-79BD-4D6D-8E59-1F8702D4EB99Q45965256-170D853C-9D72-45DC-BDA6-3451E8B19E91Q46453006-FDD8139B-4DAE-4A32-8827-8D54F17A0061Q47997995-A9E6D819-1636-424C-B5D5-FAECDDAF9B14Q48064134-7C9C7D3B-E965-4615-A1CD-413EF765AF9DQ48583756-66390A75-E570-4E78-AA5F-92ABB464414A
P2860
Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson's disease in Sweden: an exploratory study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Short-term cost and health con ...... Sweden: an exploratory study.
@en
Short-term cost and health con ...... Sweden: an exploratory study.
@nl
type
label
Short-term cost and health con ...... Sweden: an exploratory study.
@en
Short-term cost and health con ...... Sweden: an exploratory study.
@nl
prefLabel
Short-term cost and health con ...... Sweden: an exploratory study.
@en
Short-term cost and health con ...... Sweden: an exploratory study.
@nl
P2093
P2860
P356
P1476
Short-term cost and health con ...... Sweden: an exploratory study.
@en
P2093
Dag Isacson
Dag Nyholm
Ivar Sønbø Kristiansen
Kerstin Bingefors
P2860
P2888
P304
P356
10.1007/BF03256150
P577
2009-01-01T00:00:00Z